Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4. [electronic resource]
Producer: 20050322Description: 568-74 p. digitalISSN:- 1478-3223
- Adult
- Aged
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Genotype
- Hepatitis C, Chronic -- diagnosis
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Liver Function Tests
- Male
- Middle Aged
- Polyethylene Glycols
- Probability
- RNA, Viral
- Recombinant Proteins
- Ribavirin -- administration & dosage
- Risk Assessment
- Saudi Arabia
- Severity of Illness Index
- Statistics, Nonparametric
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.